The Sniff Test: StemCells can’t fix its problems with a reverse split, or by burying bad news

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 31 May, 2016 by The TZ Newswire Staff

The Sniff Test: StemCells can’t fix its problems with a reverse split, or by burying bad news

StemCells couldn’t stop its stock from again plunging below $1, by putting the news about it winding down operations at the bottom of a press release about trial results.
read more

See also
- Next Article Hasbro is Transforming into a Winner
- Previous Article The Margin: How two buckets of pennies turned one sympathetic speeder into an Internet villain
Editorial Calender

May 2016

M T W T F S S

1

2 3 4 5 6 7 8

9 10 11 12 13 14 15

16 17 18 19 20 21 22

23 24 25 26 27 28 29

30 31

« Apr Jun »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 31 May, 2016 by The TZ Newswire Staff

The Sniff Test: StemCells can’t fix its problems with a reverse split, or by burying bad news

See also

Editorial Calender

Recent Tags